2018 Global Cancer Monoclonal Antibodies Industry Report - History, Present and Future

January 2019 | 150 pages | ID: 26E75858EE3PEN
Prof Research

Abstracts

The global market size of Cancer Monoclonal Antibodies is $XX million in 2017 with XX CAGR from 2013 to 2017, and it is expected to reach $XX million by the end of 2023 with a CAGR of XX% from 2018 to 2023.

There are 3 key segments covered in this report: geography segment, end use/application segment and competitor segment.

For geography segment, regional supply, application-wise and type-wise demand, major players, price is presented from 2013 to 2023. This report coverss following regions:

• North America
• South America
• Asia & Pacific
• Europe
• MEA (Middle East and Africa)

The key countries in each region are taken into consideration as well, such as United States, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy, Spain, CIS, and Brazil etc.

For end use/application segment, this report focuses on the status and outlook for key applications. End users also can be listed.

For competitor segment, the report includes global key players of Cancer Monoclonal Antibodies as well as some small players. The compnaies include:

F. Hoffmann-La Roche, Amgen, Bristol-Myers Squibb, Takeda Pharmaceuticals, AstraZeneca, Bayer, Merck, Janssen Biotech, Novartis, OncoMed Pharmaceuticals, Pfizer, Eli Lilly, Sanofi, TG Therapeutics, CT et al.

The information for each competitor includes:

• Company Profile
• Main Business Information
• SWOT Analysis
• Sales, Revenue, Price and Gross Margin
• Market Share

We also can offer customized report to fulfill special requirements of our clients.

Contents

CHAPTER 1 EXECUTIVE SUMMARY

CHAPTER 2 ABBREVIATION AND ACRONYMS

CHAPTER 3 PREFACE

3.1 Research Scope
3.2 Research Methodology
  3.2.1 Data Collection
  3.2.2 Data Analysis
  3.2.3 Data Validation
3.3 Research Sources
  3.3.1 Primary Sources
  3.3.2 Secondary Sources
  3.3.3 Assumptions

CHAPTER 4 MARKET LANDSCAPE

4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users

CHAPTER 5 MARKET TREND ANALYSIS

5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats

CHAPTER 6 INDUSTRY CHAIN ANALYSIS

6.1 Upstream/Suppliers Analysis
6.2 Cancer Monoclonal Antibodies Analysis
  6.2.1 Technology Analysis
  6.2.2 Cost Analysis
  6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users

CHAPTER 7 LATEST MARKET DYNAMICS

7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics

CHAPTER 8 TRADING ANALYSIS

8.1 Export of Cancer Monoclonal Antibodies by Region
8.2 Import of Cancer Monoclonal Antibodies by Region
8.3 Balance of Trade

CHAPTER 9 HISTORICAL AND CURRENT CANCER MONOCLONAL ANTIBODIES MARKET IN NORTH AMERICA (2013-2018)

9.1 Cancer Monoclonal Antibodies Supply
9.2 Cancer Monoclonal Antibodies Demand by End Use
9.3 Competition by Players/Suppliers
9.4 Type Segmentation and Price
9.5 Key Countries Analysis

CHAPTER 10 HISTORICAL AND CURRENT CANCER MONOCLONAL ANTIBODIES MARKET IN SOUTH AMERICA (2013-2018)

10.1 Cancer Monoclonal Antibodies Supply
10.2 Cancer Monoclonal Antibodies Demand by End Use
10.3 Competition by Players/Suppliers
10.4 Type Segmentation and Price
10.5 Key Countries Analysis

CHAPTER 11 HISTORICAL AND CURRENT CANCER MONOCLONAL ANTIBODIES MARKET IN ASIA & PACIFIC (2013-2018)

11.1 Cancer Monoclonal Antibodies Supply
11.2 Cancer Monoclonal Antibodies Demand by End Use
11.3 Competition by Players/Suppliers
11.4 Type Segmentation and Price
11.5 Key Countries Analysis

CHAPTER 12 HISTORICAL AND CURRENT CANCER MONOCLONAL ANTIBODIES MARKET IN EUROPE (2013-2018)

12.1 Cancer Monoclonal Antibodies Supply
12.2 Cancer Monoclonal Antibodies Demand by End Use
12.3 Competition by Players/Suppliers
12.4 Type Segmentation and Price
12.5 Key Countries Analysis

CHAPTER 13 HISTORICAL AND CURRENT CANCER MONOCLONAL ANTIBODIES MARKET IN MEA (2013-2018)

13.1 Cancer Monoclonal Antibodies Supply
13.2 Cancer Monoclonal Antibodies Demand by End Use
13.3 Competition by Players/Suppliers
13.4 Type Segmentation and Price
13.5 Key Countries Analysis

CHAPTER 14 SUMMARY FOR GLOBAL CANCER MONOCLONAL ANTIBODIES MARKET (2013-2018)

14.1 Cancer Monoclonal Antibodies Supply
14.2 Cancer Monoclonal Antibodies Demand by End Use
14.3 Competition by Players/Suppliers
14.4 Type Segmentation and Price

CHAPTER 15 GLOBAL CANCER MONOCLONAL ANTIBODIES MARKET FORECAST (2019-2023)

15.1 Cancer Monoclonal Antibodies Supply Forecast
15.2 Cancer Monoclonal Antibodies Demand Forecast
15.3 Competition by Players/Suppliers
15.4 Type Segmentation and Price Forecast

CHAPTER 16 COMPANY PROFILE(F. HOFFMANN-LA ROCHE, AMGEN, BRISTOL-MYERS SQUIBB, TAKEDA PHARMACEUTICALS, ASTRAZENECA, BAYER, MERCK, JANSSEN BIOTECH, NOVARTIS, ONCOMED PHARMACEUTICALS, PFIZER, ELI LILLY, SANOFI, TG THERAPEUTICS, CT ET AL.)

16.1 Company A
  16.1.1 Company Profile
  16.1.2 Main Business and Cancer Monoclonal Antibodies Information
  16.1.3 SWOT Analysis of Company A
  16.1.4 Company A Cancer Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2013-2018)
16.2 Company B
  16.2.1 Company Profile
  16.2.2 Main Business and Cancer Monoclonal Antibodies Information
  16.2.3 SWOT Analysis of Company B
  16.2.4 Company B Cancer Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2013-2018)
16.3 Company C
  16.3.1 Company Profile
  16.3.2 Main Business and Cancer Monoclonal Antibodies Information
  16.3.3 SWOT Analysis of Company C
  16.3.4 Company C Cancer Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2013-2018)
16.4 Company D
  16.4.1 Company Profile
  16.4.2 Main Business and Cancer Monoclonal Antibodies Information
  16.4.3 SWOT Analysis of Company D
  16.4.4 Company D Cancer Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2013-2018)
16.5 Company E
  16.5.1 Company Profile
  16.5.2 Main Business and Cancer Monoclonal Antibodies Information
  16.5.3 SWOT Analysis of Company E
  16.5.4 Company E Cancer Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2013-2018)
16.6 Company F
  16.6.1 Company Profile
  16.6.2 Main Business and Cancer Monoclonal Antibodies Information
  16.6.3 SWOT Analysis of Company F
  16.6.4 Company F Cancer Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2013-2018)
16.7 Company G
  16.7.1 Company Profile
  16.7.2 Main Business and Cancer Monoclonal Antibodies Information
  16.7.3 SWOT Analysis of Company G
  16.7.4 Company G Cancer Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2013-2018)

Tables & Figures

TABLES AND FIGURES

Table Abbreviation and Acronyms List
Table Research Scope of Cancer Monoclonal Antibodies Report
Table Primary Sources of Cancer Monoclonal Antibodies Report
Table Secondary Sources of Cancer Monoclonal Antibodies Report
Table Major Assumptions of Cancer Monoclonal Antibodies Report
Figure Cancer Monoclonal Antibodies Picture
Table Cancer Monoclonal Antibodies Classification
Table Cancer Monoclonal Antibodies Applications List
Table Drivers of Cancer Monoclonal Antibodies Market
Table Restraints of Cancer Monoclonal Antibodies Market
Table Opportunities of Cancer Monoclonal Antibodies Market
Table Threats of Cancer Monoclonal Antibodies Market
Table Key Raw Material of Cancer Monoclonal Antibodies and Its Suppliers
Table Key Technologies of Cancer Monoclonal Antibodies
Table Cost Structure of Cancer Monoclonal Antibodies
Table Market Channel of Cancer Monoclonal Antibodies
Table Cancer Monoclonal Antibodies Application and Key End Users List
Table Latest News of Cancer Monoclonal Antibodies Industry
Table Recently Merger and Acquisition List of Cancer Monoclonal Antibodies Industry
Table Recently Planned/Future Project List of Cancer Monoclonal Antibodies Industry
Table Policy Dynamics Update of Cancer Monoclonal Antibodies Industry
Table 2013-2023 Export of Cancer Monoclonal Antibodies by Region
Table 2013-2023 Import of Cancer Monoclonal Antibodies by Region
Table 2013-2023 Balance of Trade of Cancer Monoclonal Antibodies
Figure 2013 2018 and 2023 Global Trade Map of Cancer Monoclonal Antibodies
Table 2013-2018 North America Supply of Cancer Monoclonal Antibodies
Figure 2013-2018 North America Cancer Monoclonal Antibodies Supply and GAGR
Table 2013-2018 North America Cancer Monoclonal Antibodies Downstream Demand List
Figure 2013-2018 North America Cancer Monoclonal Antibodies Downstream Demand and CAGR
Figure 2013 Major Players Market Share in North America
Figure 2018 Major Players Market Share in North America
Table 2013-2018 North America Cancer Monoclonal Antibodies Demand by Type
Figure 2013-2018 North America Cancer Monoclonal Antibodies Price
Table 2013-2018 Key Countries Supply of Cancer Monoclonal Antibodies in North America
Table 2013-2018 Key Countries Market Share of Supply in North America
Table 2013-2018 Key Countries Demand of Cancer Monoclonal Antibodies in North America
Table 2013-2018 Key Countries Market Share of Demand in North America
Table 2013-2018 South America Supply of Cancer Monoclonal Antibodies
Figure 2013-2018 South America Cancer Monoclonal Antibodies Supply and GAGR
Table 2013-2018 South America Cancer Monoclonal Antibodies Downstream Demand List
Figure 2013-2018 South America Cancer Monoclonal Antibodies Downstream Demand and CAGR
Figure 2013 Major Players Market Share in South America
Figure 2018 Major Players Market Share in South America
Table 2013-2018 South America Cancer Monoclonal Antibodies Demand by Type
Figure 2013-2018 South America Cancer Monoclonal Antibodies Price
Table 2013-2018 Key Countries Supply of Cancer Monoclonal Antibodies in South America
Table 2013-2018 Key Countries Market Share of Supply in South America
Table 2013-2018 Key Countries Demand of Cancer Monoclonal Antibodies in South America
Table 2013-2018 Key Countries Market Share of Demand in South America
Table 2013-2018 Asia & Pacific Supply of Cancer Monoclonal Antibodies
Figure 2013-2018 Asia & Pacific Cancer Monoclonal Antibodies Supply and GAGR
Table 2013-2018 Asia & Pacific Cancer Monoclonal Antibodies Downstream Demand List
Figure 2013-2018 Asia & Pacific Cancer Monoclonal Antibodies Downstream Demand and CAGR
Figure 2013 Major Players Market Share in Asia & Pacific
Figure 2018 Major Players Market Share in Asia & Pacific
Table 2013-2018 Asia & Pacific Cancer Monoclonal Antibodies Demand by Type
Figure 2013-2018 Asia & Pacific Cancer Monoclonal Antibodies Price
Table 2013-2018 Key Countries Supply of Cancer Monoclonal Antibodies in Asia & Pacific
Table 2013-2018 Key Countries Market Share of Supply in Asia & Pacific
Table 2013-2018 Key Countries Demand of Cancer Monoclonal Antibodies in Asia & Pacific
Table 2013-2018 Key Countries Market Share of Demand in Asia & Pacific
Table 2013-2018 Europe Supply of Cancer Monoclonal Antibodies
Figure 2013-2018 Europe Cancer Monoclonal Antibodies Supply and GAGR
Table 2013-2018 Europe Cancer Monoclonal Antibodies Downstream Demand List
Figure 2013-2018 Europe Cancer Monoclonal Antibodies Downstream Demand and CAGR
Figure 2013 Major Players Market Share in Europe
Figure 2018 Major Players Market Share in Europe
Table 2013-2018 Europe Cancer Monoclonal Antibodies Demand by Type
Figure 2013-2018 Europe Cancer Monoclonal Antibodies Price
Table 2013-2018 Key Countries Supply of Cancer Monoclonal Antibodies in Europe
Table 2013-2018 Key Countries Market Share of Supply in Europe
Table 2013-2018 Key Countries Demand of Cancer Monoclonal Antibodies in Europe
Table 2013-2018 Key Countries Market Share of Demand in Europe
Table 2013-2018 MEA Supply of Cancer Monoclonal Antibodies
Figure 2013-2018 MEA Cancer Monoclonal Antibodies Supply and GAGR
Table 2013-2018 MEA Cancer Monoclonal Antibodies Downstream Demand List
Figure 2013-2018 MEA Cancer Monoclonal Antibodies Downstream Demand and CAGR
Figure 2013 Major Players Market Share in MEA
Figure 2018 Major Players Market Share in MEA
Table 2013-2018 MEA Cancer Monoclonal Antibodies Demand by Type
Figure 2013-2018 MEA Cancer Monoclonal Antibodies Price
Table 2013-2018 Key Countries Supply of Cancer Monoclonal Antibodies in MEA
Table 2013-2018 Key Countries Market Share of Supply in MEA
Table 2013-2018 Key Countries Demand of Cancer Monoclonal Antibodies in MEA
Table 2013-2018 Key Countries Market Share of Demand in MEA
Table 2013-2018 Global Supply of Cancer Monoclonal Antibodies by Region
Figure 2013-2018 Global Supply and CAGR of Cancer Monoclonal Antibodies by Region
Table 2013-2018 Global Cancer Monoclonal Antibodies Downstream Demand List by Region
Figure 2013-2018 Global Cancer Monoclonal Antibodies Downstream Demand and CAGR by Region
Figure 2013 Global Major Players Market Share
Figure 2018 Global Major Players Market Share
Table 2013-2018 Global Cancer Monoclonal Antibodies Type-wise Demand by Region
Figure 2013-2018 Global Cancer Monoclonal Antibodies Price
Table Main Business and Cancer Monoclonal Antibodies Information of Company A
Table SWOT Analysis of Company A
Table 2013-2018 Company A Cancer Monoclonal Antibodies Sales, Revenue, Price, Cost and Gross Margin List
Figure 2013-2018 Company A Cancer Monoclonal Antibodies Sales Revenue and Growth Rate
Figure 2013-2018 Company A Cancer Monoclonal Antibodies Market Share
Table Main Business and Cancer Monoclonal Antibodies Information of Company B
Table SWOT Analysis of Company B
Table 2013-2018 Company B Cancer Monoclonal Antibodies Sales, Revenue, Price, Cost and Gross Margin List
Figure 2013-2018 Company B Cancer Monoclonal Antibodies Sales Revenue and Growth Rate
Figure 2013-2018 Company B Cancer Monoclonal Antibodies Market Share
Table Main Business and Cancer Monoclonal Antibodies Information of Company C
Table SWOT Analysis of Company C
Table 2013-2018 Company C Cancer Monoclonal Antibodies Sales, Revenue, Price, Cost and Gross Margin List
Figure 2013-2018 Company C Cancer Monoclonal Antibodies Sales Revenue and Growth Rate
Figure 2013-2018 Company C Cancer Monoclonal Antibodies Market Share
Table Main Business and Cancer Monoclonal Antibodies Information of Company D
Table SWOT Analysis of Company D
Table 2013-2018 Company D Cancer Monoclonal Antibodies Sales, Revenue, Price, Cost and Gross Margin List
Figure 2013-2018 Company D Cancer Monoclonal Antibodies Sales Revenue and Growth Rate
Figure 2013-2018 Company D Cancer Monoclonal Antibodies Market Share
Table Main Business and Cancer Monoclonal Antibodies Information of Company E
Table SWOT Analysis of Company E
Table 2013-2018 Company E Cancer Monoclonal Antibodies Sales, Revenue, Price, Cost and Gross Margin List
Figure 2013-2018 Company E Cancer Monoclonal Antibodies Sales Revenue and Growth Rate
Figure 2013-2018 Company E Cancer Monoclonal Antibodies Market Share
Table Main Business and Cancer Monoclonal Antibodies Information of Company F
Table SWOT Analysis of Company F
Table 2013-2018 Company F Cancer Monoclonal Antibodies Sales, Revenue, Price, Cost and Gross Margin List
Figure 2013-2018 Company F Cancer Monoclonal Antibodies Sales Revenue and Growth Rate
Figure 2013-2018 Company F Cancer Monoclonal Antibodies Market Share
Table Main Business and Cancer Monoclonal Antibodies Information of Company G
Table SWOT Analysis of Company G
Table 2013-2018 Company G Cancer Monoclonal Antibodies Sales, Revenue, Price, Cost and Gross Margin List
Figure 2013-2018 Company G Cancer Monoclonal Antibodies Sales Revenue and Growth Rate
Figure 2013-2018 Company G Cancer Monoclonal Antibodies Market Share